| |
|
|
|
Hemispherx Biopharma
|
|
0.34 0 (+0.00%) |
9/22/2017 3:59pm |
|
Open: |
0.34 |
Pre close: |
0.34 |
Target:
|
0.43
|
|
High: |
0.34 |
Low: |
0.32 |
Resistance:
|
0.37
0.41
|
|
Volume: |
164,771 |
Market Cap: |
9.92M |
Support:
|
0.30
0.25
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.33
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
0.35  |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
0.47 |
Stochastic Oscillator |
%K(14,3):
|
41.58 |
|
MA(250): |
0.63 |
%D(3): |
35.80 |
|
Average Volume(K) |
3-Month: |
30084
|
52-Week |
High:
|
1.32 |
|
10-Days: |
16876 |
Low: |
0.30 |
|
RSI |
RSI(14):
|
41.45 |
Change(%): |
-73.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.370 |
Return on Equity (ttm) |
-65.1 |
Shares Out. (M) |
29.17 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-43.2 |
Shares Float (M) |
28.52 |
|
EPS Est. Next Year |
-0.030 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.79 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
1320.0 |
% Held by Institutions |
10.40 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
-0.035 |
Shares Short (K) |
783 |
|
Book Value (p.s.) |
0.360 |
EBITDA (p.s.) |
-0.415 |
P/E |
-0.89 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.92 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.39 |
P/S |
964360192.00 |
|
Operating Margin |
-3924.78 |
Levered Free Cash Flow
(M) |
-5.95 |
P/CF |
-0.93 |
|
|
|
|
|
|
|
